Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Current Leases (2019 - 2023)

Historic Current Leases for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to $1.4 million.

  • ADC Therapeutics' Current Leases rose 6970.06% to $1.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $1.4 million, marking a year-over-year increase of 6970.06%. This contributed to the annual value of $1.1 million for FY2022, which is 10650835.76% up from last year.
  • According to the latest figures from Q3 2023, ADC Therapeutics' Current Leases is $1.4 million, which was up 6970.06% from $1.6 million recorded in Q2 2023.
  • Over the past 5 years, ADC Therapeutics' Current Leases peaked at $1.6 million during Q2 2023, and registered a low of $1029.0 during Q4 2021.
  • For the 5-year period, ADC Therapeutics' Current Leases averaged around $862727.1, with its median value being $952500.0 (2019).
  • Within the past 5 years, the most significant YoY rise in ADC Therapeutics' Current Leases was 10650835.76% (2022), while the steepest drop was 1749.01% (2022).
  • Over the past 5 years, ADC Therapeutics' Current Leases (Quarter) stood at $924000.0 in 2019, then crashed by 99.89% to $1051.0 in 2020, then decreased by 2.09% to $1029.0 in 2021, then soared by 106508.36% to $1.1 million in 2022, then rose by 29.17% to $1.4 million in 2023.
  • Its Current Leases stands at $1.4 million for Q3 2023, versus $1.6 million for Q2 2023 and $1.4 million for Q1 2023.